Kun Lv
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 5%
- Immune cells in cancer
Papers in ⓘ
-
- RNA modifications and cancer 18
- RNA Research and Splicing 11
- Circular RNAs in diseases 8
- Extracellular vesicles in disease 6
-
- Cancer-related molecular mechanisms research 20
- MicroRNA in disease regulation 12
- Co-authors
- Mengying Zhang (21 shared papers)Xueqin Li (16 shared papers)Hui Yang (21 shared papers)Min Zhong (11 shared papers)Qifeng Suo (5 shared papers)Xiaolong Zhu (16 shared papers)Yingying Zhang (5 shared papers)Yingying Zhang (8 shared papers)
In The Last Decade
Kun Lv
64 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 742
- Immunology 448
- Molecular Biology 1.1k
- Cardiology and Cardiovascular Medicine 162
- Pulmonary and Respiratory Medicine 232
Countries citing papers authored by Kun Lv
This map shows the geographic impact of Kun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Lv more than expected).
Fields of papers citing papers by Kun Lv
This network shows the impact of papers produced by Kun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Lv. The network helps show where Kun Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer Hit paper breakdown → | 2021 | 190 |
| 2 | 2013 | 163 | |
| 3 | 2017 | 87 | |
| 4 | 2016 | 85 | |
| 5 | 2021 | 78 | |
| 6 | 2023 | 67 | |
| 7 | 2021 | 56 | |
| 8 | 2017 | 54 | |
| 9 | Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles Hit paper breakdown → | 2024 | 52 |
| 10 | 2018 | 38 | |
| 11 | 2020 | 37 | |
| 12 | 2024 | 35 | |
| 13 | 2020 | 34 | |
| 14 | 2021 | 34 | |
| 15 | 2024 | 32 | |
| 16 | 2012 | 32 | |
| 17 | 2020 | 32 | |
| 18 | 2024 | 31 | |
| 19 | 2011 | 31 | |
| 20 | 2012 | 31 |
About Kun Lv
Kun Lv is a scholar working on Molecular Biology, Cancer Research, Immunology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (18 papers), MicroRNA in disease regulation (12 papers), RNA Research and Splicing (11 papers), Circular RNAs in diseases (8 papers), Viral Infections and Immunology Research (6 papers), Ferroptosis and cancer prognosis (6 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Cancer Research (742 citations), Immunology (448 citations), Molecular Biology (1.1k citations), Cardiology and Cardiovascular Medicine (162 citations) and Pulmonary and Respiratory Medicine (232 citations). Kun Lv has collaborated with scholars based in China, Ireland and Japan. Frequent co-authors include Mengying Zhang, Xueqin Li, Hui Yang, Min Zhong, Qifeng Suo, Xiaolong Zhu, Yingying Zhang, Yingying Zhang, Weiya Pei and Mingzhe Ma. Their work appears in journals such as European Journal of Pharmacology, Journal of Cellular and Molecular Medicine, Scientific Reports, Cancer Cell International and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.